{"id":"https://openalex.org/W4401552124","doi":"https://doi.org/10.1016/j.ejcskn.2024.100260","title":"LASSO logistic regression reveals a mixed MiRNA and serum-marker classifier for prediction of immunotherapy response in liquid biopsies of melanoma patients","display_name":"LASSO logistic regression reveals a mixed MiRNA and serum-marker classifier for prediction of immunotherapy response in liquid biopsies of melanoma patients","publication_year":2024,"publication_date":"2024-08-12","ids":{"openalex":"https://openalex.org/W4401552124","doi":"https://doi.org/10.1016/j.ejcskn.2024.100260"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejcskn.2024.100260","doi":"https://doi.org/10.1016/j.ejcskn.2024.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcskn.2024.100260","pdf_url":null,"source":{"id":"https://openalex.org/S4387288999","display_name":"EJC Skin Cancer","issn_l":"2772-6118","issn":["2772-6118"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC Skin Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.ejcskn.2024.100260","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021216481","display_name":"Marc Bender","orcid":"https://orcid.org/0000-0003-2304-1473","observed_orcids":["https://orcid.org/0000-0003-2304-1473"]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marc Bender","raw_affiliation_strings":["Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072055297","display_name":"I-Peng Chen","orcid":"https://orcid.org/0000-0001-8265-6334","observed_orcids":["https://orcid.org/0000-0001-8265-6334"]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I.-Peng Chen","raw_affiliation_strings":["Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066989252","display_name":"Leonie Bluhm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Leonie Bluhm","raw_affiliation_strings":["Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042724544","display_name":"Peter Mohr","orcid":"https://orcid.org/0000-0002-7328-7407","observed_orcids":["https://orcid.org/0000-0002-7328-7407"]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Mohr","raw_affiliation_strings":["Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088928605","display_name":"Beate Volkmer","orcid":"https://orcid.org/0000-0001-9218-8650","observed_orcids":["https://orcid.org/0000-0001-9218-8650"]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Beate Volkmer","raw_affiliation_strings":["Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010308421","display_name":"R. Greinert","orcid":"https://orcid.org/0000-0003-3479-9968","observed_orcids":["https://orcid.org/0000-0003-3479-9968"]},"institutions":[{"id":"https://openalex.org/I4210138735","display_name":"Elbe Kliniken Stade-Buxtehude","ror":"https://ror.org/04psvb108","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210138735"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"R\u00fcdiger Greinert","raw_affiliation_strings":["Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany","institution_ids":["https://openalex.org/I4210138735"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010308421"],"corresponding_institution_ids":["https://openalex.org/I4210138735"],"apc_list":{"value":2200,"currency":"USD","value_usd":2200},"apc_paid":{"value":2200,"currency":"USD","value_usd":2200},"fwci":0.5134,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62414573,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"2","issue":null,"first_page":"100260","last_page":"100260"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8788999915122986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8788999915122986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.061900001019239426,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.0284000001847744,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9679999947547913},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.9929999709129333},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/plasma-mirna","display_name":"plasma microRNA","score":0.718999981880188},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.9779999852180481},{"id":"https://openalex.org/keywords/lasso-logistic-regression","display_name":"LASSO logistic regression","score":0.902999997138977},{"id":"https://openalex.org/keywords/mir-132-3p","display_name":"miR-132-3p","score":0.9160000085830688},{"id":"https://openalex.org/keywords/mir-137","display_name":"miR-137","score":0.9660000205039978},{"id":"https://openalex.org/keywords/mir-197","display_name":"miR-197","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mir-214","display_name":"miR-214","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.9739999771118164},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9900000095367432},{"id":"https://openalex.org/keywords/s100-protein","display_name":"S-100 protein","score":0.9240000247955322},{"id":"https://openalex.org/keywords/eosinophils","display_name":"eosinophils","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.8124594688415527},{"id":"https://openalex.org/C37616216","wikidata":"https://www.wikidata.org/wiki/Q3218363","display_name":"Lasso (programming language)","level":2,"score":0.605674684047699},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5446592569351196},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5347342491149902},{"id":"https://openalex.org/C95623464","wikidata":"https://www.wikidata.org/wiki/Q1096149","display_name":"Classifier (UML)","level":2,"score":0.5252741575241089},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4756081700325012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45928192138671875},{"id":"https://openalex.org/C83546350","wikidata":"https://www.wikidata.org/wiki/Q1139051","display_name":"Regression","level":2,"score":0.4405383765697479},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.423086017370224},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.3503771126270294},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.22619587182998657},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.223992258310318},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.20974409580230713},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17403212189674377},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.12852290272712708},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejcskn.2024.100260","doi":"https://doi.org/10.1016/j.ejcskn.2024.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcskn.2024.100260","pdf_url":null,"source":{"id":"https://openalex.org/S4387288999","display_name":"EJC Skin Cancer","issn_l":"2772-6118","issn":["2772-6118"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC Skin Cancer","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:68c64456478a458998883d0bdc45922b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/68c64456478a458998883d0bdc45922b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EJC Skin Cancer, Vol 2, Iss , Pp 100260- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ejcskn.2024.100260","doi":"https://doi.org/10.1016/j.ejcskn.2024.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejcskn.2024.100260","pdf_url":null,"source":{"id":"https://openalex.org/S4387288999","display_name":"EJC Skin Cancer","issn_l":"2772-6118","issn":["2772-6118"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJC Skin Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320335974","display_name":"Mundipharma Research GmbH and Co.KG","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1942858370","https://openalex.org/W1994158976","https://openalex.org/W2019607817","https://openalex.org/W2090387552","https://openalex.org/W2115501259","https://openalex.org/W2127254281","https://openalex.org/W2133942235","https://openalex.org/W2151480498","https://openalex.org/W2152897456","https://openalex.org/W2166662937","https://openalex.org/W2295795165","https://openalex.org/W2340636398","https://openalex.org/W2392329487","https://openalex.org/W2396808887","https://openalex.org/W2549056955","https://openalex.org/W2581911737","https://openalex.org/W2739567144","https://openalex.org/W2740169839","https://openalex.org/W2746148521","https://openalex.org/W2747774814","https://openalex.org/W2754127264","https://openalex.org/W2781894357","https://openalex.org/W2784307064","https://openalex.org/W2808441345","https://openalex.org/W2811006127","https://openalex.org/W2811212358","https://openalex.org/W2900900388","https://openalex.org/W2920526988","https://openalex.org/W2924956524","https://openalex.org/W2943831157","https://openalex.org/W2957955537","https://openalex.org/W2968784028","https://openalex.org/W2988485068","https://openalex.org/W2991013751","https://openalex.org/W3000082715","https://openalex.org/W3003394374","https://openalex.org/W3037103765","https://openalex.org/W3076139199","https://openalex.org/W3080512088","https://openalex.org/W3211911923","https://openalex.org/W4207051106","https://openalex.org/W4211139125","https://openalex.org/W4211223138","https://openalex.org/W4229873072","https://openalex.org/W4297339120","https://openalex.org/W4310244189","https://openalex.org/W4368367317","https://openalex.org/W4388774193","https://openalex.org/W6782344720"],"related_works":["https://openalex.org/W2784922865","https://openalex.org/W4310707612","https://openalex.org/W4407182183","https://openalex.org/W4387747122","https://openalex.org/W4379281885","https://openalex.org/W3105094596","https://openalex.org/W3137909560","https://openalex.org/W3106283519","https://openalex.org/W4308400007","https://openalex.org/W3103134014"],"abstract_inverted_index":{"Introduction":[0],"Cutaneous":[1],"malignant":[2],"melanoma":[3,57],"suffers":[4],"from":[5],"the":[6,30,99,108,158,178,189,194,198,235],"highest":[7],"metastasis":[8],"rate":[9],"and":[10,39,62,141,149,152,217,224,229],"mortality":[11],"among":[12],"different":[13],"skin":[14],"cancer":[15],"entities.":[16],"However,":[17],"with":[18,52,125,226],"emerging":[19],"immune":[20],"checkpoint":[21],"inhibitor":[22],"(ICI)":[23],"therapy,":[24],"prognosis":[25],"has":[26],"significantly":[27,162],"improved":[28],"over":[29],"last":[31],"years.":[32],"To":[33],"better":[34],"assess":[35],"treatment":[36],"response":[37,127],"stable":[38],"reliable":[40],"biomarkers":[41],"are":[42],"needed.":[43],"Methods":[44],"We":[45],"gathered":[46],"blood":[47],"samples":[48],"of":[49,86,188,197,205,211,237],"81":[50],"patients":[51],"predominantly":[53],"AJCC":[54],"Stage":[55],"III/IV":[56],"to":[58,71,80,98,101,115,164],"evaluate":[59],"serum":[60],"markers":[61,76,137],"plasma-derived":[63],"miRNAs.":[64],"A":[65],"machine":[66,169],"learning":[67,170],"model":[68,192,208],"was":[69,96,113],"developed":[70],"predict":[72,102],"immunotherapy":[73],"response.":[74],"Serum":[75,136],"were":[77,89,157],"measured":[78],"according":[79],"standard":[81],"clinical":[82],"routines.":[83],"Expression":[84],"levels":[85],"61":[87],"miRNAs":[88],"quantified":[90],"via":[91],"flowcytometry.":[92],"LASSO":[93,175,191],"logistic":[94],"regression":[95],"fit":[97],"data":[100],"therapy":[103,126,155,165],"outcome,":[104],"employing":[105],"AUROC":[106],"as":[107],"performance":[109],"metric.":[110],"Nested":[111],"cross-validation":[112],"used":[114],"mitigate":[116],"overfitting.":[117],"Results":[118],"Plasma-derived":[119],"miRNA":[120],"expression":[121,210],"exhibited":[122],"significant":[123,145],"association":[124],"for":[128,234],"5":[129],"miRNAs:":[130],"miR-132\u20133p,":[131],"miR-137,":[132],"miR-197,":[133],"miR-214,":[134],"miR-514a-3p.":[135],"LDH,":[138,214],"CRP,":[139],"S100":[140],"eosinophile":[142],"concentration":[143],"showed":[144],"differences":[146],"between":[147],"Responders":[148,223],"Non-Responders.":[150],"Age":[151],"previous":[153],"anti-BRAF":[154],"(BRAFi/MEKi)":[156],"only":[159],"demographic":[160],"parameters":[161],"related":[163],"outcome.":[166],"Among":[167],"six":[168],"models":[171],"tested,":[172],"a":[173,212],"relaxed":[174,190],"approach":[176],"on":[177],"entire":[179],"dataset":[180],"performed":[181],"best":[182],"(AUC":[183],"=":[184],"0.851).":[185],"Conclusion":[186],"Validation":[187],"in":[193],"outer":[195],"loop":[196],"nested":[199],"cross":[200],"validation":[201,236],"yielded":[202],"an":[203],"AUC":[204],"0.847.":[206],"This":[207],"incorporated":[209],"miRNA-quartet,":[213],"patient":[215],"age":[216],"prior":[218],"BRAFi/MEKi.":[219],"It":[220],"effectively":[221],"identifies":[222],"Non-Responders":[225],"high":[227],"sensitivity":[228],"specificity,":[230],"presenting":[231],"promising":[232],"candidates":[233],"future":[238],"biomarkers.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2024-08-14T00:00:00"}